The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 46 | — | 20.1x | Near average | |
Growth | 47 | 74.9% | 5.6% | Near average | |
Quality | 47 | 74.3% | 7.6% | Near average | |
Safety | 36 | 3.4x | 0.4x | Near average | |
Capital Return | 78 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Carlsmed, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Carlsmed, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Carlsmed stock shows a state of uncertainty in analyst estimates, as the number of analysts contributing to the price target has dropped from 4 to only 1 in recent updates, despite the average price target stabilizing at 20.67 dollars. This contraction in coverage indicates a gap in currently available data, making reliance on the Consensus less accurate due to the absence of statistical Dispersion among multiple opinions.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.